Quick Answer
RELMADA THERAPEUTICS, INC. reported Shares Outstanding of 73.33 million shares for fiscal year 2025.
RELMADA THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 73.33M | +143.0% |
| 2024 | 30.17M | +0.2% |
| 2023 | 30.10M | +0.0% |
| 2022 | 30.10M | +8.5% |
| 2021 | 27.74M | +69.8% |
| 2020 | 16.33M | +13.0% |
| 2019 | 14.46M | +48.4% |
| 2019 | 9.74M | -22.4% |
| 2018 | 12.55M | +0.2% |
| 2017 | 12.53M | +4.1% |
| 2016 | 12.04M | +11.7% |
| 2015 | 10.78M | +33.7% |
| 2014 | 8.06M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 33.19M | +10.0% | +0.0% |
| June 30, 2025 | 33.19M | +10.0% | +0.0% |
| March 31, 2025 | 33.19M | +10.0% | +10.0% |
| December 31, 2024 | 30.17M | +0.2% | +0.0% |
| September 30, 2024 | 30.17M | +0.2% | +0.0% |
| June 30, 2024 | 30.17M | +0.2% | +0.0% |
| March 31, 2024 | 30.17M | +0.2% | +0.2% |
| December 31, 2023 | 30.10M | +0.0% | +0.0% |
- RELMADA THERAPEUTICS, INC. showed an increase of +143.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, RELMADA THERAPEUTICS, INC.’s shares outstanding has grown by 810.0% (from 8.06 million shares to 73.33 million shares).
- The most recent figure is from RELMADA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: